| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Gm Interventional Oncology
1 company
Muir Kevin serves as a Gm Interventional Oncology at DCTH. Those positions are worth an estimated $311K at current prices.
The biggest single holding is DCTH (~$311K) as Gm Interventional Oncology.
No transactions found
Try adjusting your filters or search criteria